HER2-specific CAR T Cells for Children With Ependymoma

Learn more about:
Related Clinical Trial
HER2-specific CAR T Cells for Children With Ependymoma ONC206 for Treatment of Newly Diagnosed or Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant Brain Tumors (PNOC 023) Study of the Effect of GM-CSF on Macrophages in Ependymoma A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas SCRT Versus Conventional RT in Children and Young Adults With Low Grade and Benign Brain Tumors A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors HUMC 1612: Optune NovoTTF-200A System Treatment of Children With Recurrent Refractory Brain/Solid Tumors and Recurrent Ependymoma Single-agent Erlotinib in Patients Previously Treated With Oral Etoposide in Protocol OSI-774-205 Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma A Trial of Surgery and Fractionated Re-Irradiation for Recurrent Ependymoma Immunotherapy for Recurrent Ependymomas in Children Treatment for Recurrent Ependymomas Using HLA-A2 Restricted Tumor Antigen Peptides in Combination With Imiquimod LET Optimized IMPT in Treating Pediatric Patients With Ependymoma Everolimus for Children With Recurrent or Progressive Ependymoma Antineoplaston Therapy in Treating Patients With Ependymoma Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma Feasibility Trial of Optune for Children With Recurrent or Progressive Supratentorial High-Grade Glioma and Ependymoma An International Clinical Program for the Diagnosis and Treatment of Children With Ependymoma Phase I Study of 5-Fluorouracil in Children and Young Adults With Recurrent Ependymoma

Recruitment Information


Administrative Informations